Results 131 to 140 of about 42,696 (223)

Human T-Lymphotropic Virus Screening of Blood Donations in England Between 2002 and 2021-Comparison of Screening Strategies. [PDF]

Clin Infect Dis
Harvala H, Davison K, Webster M, Reynolds C, Taylor GP.   +4 more
europepmc   +1 more source

Human T-lymphotropic virus in Irish blood donors: Impact on future testing strategy. [PDF]

Transfusion, 2022
Williams P, O'Flaherty N, Field S, Waters A.   +3 more
europepmc   +1 more source

An Overview of Human T-Lymphotropic Virus Type 1 Lung Injury. [PDF]

Front Immunol, 2022
Dias ÁRN, Falcão LFM, Quaresma JAS.
europepmc   +1 more source

Sustained inflammation during human T-lymphotropic virus type 1 infection: a wildfire contributing to disease progression. [PDF]

Front Med (Lausanne)
Shegefti S, Alaei M, Ghahari N, Telittchenko R, Hanafi SB, Isnard S, Routy JP, Olagnier D, van Grevenynghe J.   +8 more
europepmc   +1 more source

Mogamulizumab for Treatment of Human T-lymphotropic Virus Type 1-Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-based Series. [PDF]

Clin Infect Dis, 2023
Meyerowitz EA, Mukerji SS, Kyle Harrold G, Erdil RM, Chen ST, Rudmann EA, Tsibris A, Venna N, Robbins GK.   +8 more
europepmc   +1 more source

Human T-Lymphotropic Virus (HTLV): Epidemiology, Genetic, Pathogenesis, and Future Challenges. [PDF]

Viruses
Branda F, Romano C, Pavia G, Bilotta V, Locci C, Azzena I, Deplano I, Pascale N, Perra M, Giovanetti M, Ciccozzi A, De Vito A, Quirino A, Marascio N, Matera G, Madeddu G, Casu M, Sanna D, Ceccarelli G, Ciccozzi M, Scarpa F.   +20 more
europepmc   +1 more source

A Textbook Case of Human T-lymphotropic Virus-1 (HTLV-1)-Induced Adult T-cell Leukemia Treated With Cyclophosphamide, Hydroxydaunorubicin, Oncovin, and Prednisone/Prednisolone (CHOP). [PDF]

Cureus, 2023
Altaf F, Qureshi ZA, Moore S, Golek TM, Chawala A.   +4 more
europepmc   +1 more source

A case of lower respiratory tract infection caused by <i>Pandoraea sputorum</i> in a human T-lymphotropic virus type 1 carrier. [PDF]

IDCases
Ogasawara T, Yamanda S, Fukuzawa K, Yamazaki Y, Doman T, Minami S, Narumi A, Saito S, Odaka T, Ono K, Shimizu H, Sugisaka J, Aiba T, Kawana S, Toi Y, Sugawara S, Kimura Y.   +16 more
europepmc   +1 more source

[Retracted] Effects of nutrients on matrix metalloproteinases in human T‑lymphotropic virus type 1 positive and negative malignant T‑lymphocytes. [PDF]

Int J Oncol, 2023
Harakeh S, Abou-Khouzam R, Damanhouri GA, Al-Hejin A, Kumosani T, Niedzwiecki A, Rath M, Barbour E, Diab-Assaf M, Azar R.   +9 more
europepmc   +1 more source

A human T-lymphotropic virus-1 carrier who developed progressive multifocal leukoencephalopathy following immunotherapy for sarcoidosis: a case report. [PDF]

BMC Neurol, 2023
Nagahori T, Shiraishi W, Nishikawa M, Matsuyoshi A, Ogura T, Yamada Y, Takahashi K, Suzuki T, Nakamichi K, Hashimoto T, Hatano T.   +10 more
europepmc   +1 more source